erythromycin

Generic: erythromycin

Labeler: cadila pharmaceuticals limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name erythromycin
Generic Name erythromycin
Labeler cadila pharmaceuticals limited
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

erythromycin 250 mg/1

Manufacturer
Cadila Pharmaceuticals Limited

Identifiers & Regulatory

Product NDC 71209-100
Product ID 71209-100_feeef834-a0cb-482c-b5bc-078be4f94e38
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213628
Listing Expiration 2026-12-31
Marketing Start 2021-10-06

Pharmacologic Class

Established (EPC)
macrolide [epc] macrolide antimicrobial [epc]
Chemical Structure
macrolides [cs]
Physiologic Effect
decreased sebaceous gland activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71209100
Hyphenated Format 71209-100

Supplemental Identifiers

RxCUI
197650 598006
UPC
0371209100052 0371209101011
UNII
63937KV33D
NUI
N0000009982 N0000175877 N0000175935 M0028311

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name erythromycin (source: ndc)
Generic Name erythromycin (source: ndc)
Application Number ANDA213628 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED in 1 BOTTLE (71209-100-01)
  • 100 TABLET, FILM COATED in 1 BOTTLE (71209-100-05)
source: ndc

Packages (2)

Ingredients (1)

erythromycin (250 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "feeef834-a0cb-482c-b5bc-078be4f94e38", "openfda": {"nui": ["N0000009982", "N0000175877", "N0000175935", "M0028311"], "upc": ["0371209100052", "0371209101011"], "unii": ["63937KV33D"], "rxcui": ["197650", "598006"], "spl_set_id": ["fae8fc38-3c60-43b8-a0f9-2c50df332505"], "pharm_class_cs": ["Macrolides [CS]"], "pharm_class_pe": ["Decreased Sebaceous Gland Activity [PE]"], "pharm_class_epc": ["Macrolide [EPC]", "Macrolide Antimicrobial [EPC]"], "manufacturer_name": ["Cadila Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (71209-100-01)", "package_ndc": "71209-100-01", "marketing_start_date": "20211006"}, {"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (71209-100-05)", "package_ndc": "71209-100-05", "marketing_start_date": "20211006"}], "brand_name": "Erythromycin", "product_id": "71209-100_feeef834-a0cb-482c-b5bc-078be4f94e38", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Macrolide Antimicrobial [EPC]", "Macrolide [EPC]", "Macrolides [CS]"], "product_ndc": "71209-100", "generic_name": "Erythromycin", "labeler_name": "Cadila Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Erythromycin", "active_ingredients": [{"name": "ERYTHROMYCIN", "strength": "250 mg/1"}], "application_number": "ANDA213628", "marketing_category": "ANDA", "marketing_start_date": "20211006", "listing_expiration_date": "20261231"}